Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Adtran
ADTN
$690M
| $551K | ﹤0.01% |
26,664
-36,631
| -58% | -$708K |
|
|
CLDT
3002
Chatham Lodging
CLDT
$615M
| $551K | ﹤0.01% |
42,768
-62,594
| -59% | -$835K |
|
3003
John B. Sanfilippo & Son
JBSS
$984M
| $550K | ﹤0.01% |
6,200
-5,127
| -45% | -$466K |
|
3004
Red Robin
RRGB
$151M
| $550K | ﹤0.01% |
16,575
-8,408
| -34% | -$287K |
|
3005
ProShares Investment Grade-Interest Rate Hedged
IGHG
$329M
| $549K | ﹤0.01% |
+7,172
| New | +$547K |
|
3006
MACOM Technology Solutions
MTSI
$20.8B
| $549K | ﹤0.01% |
8,574
-38,496
| -82% | -$2.23M |
|
3007
CALL
BioCryst Pharmaceuticals
BCRX
$2.43B
| $544K | ﹤0.01% |
34,400
-17,000
| -33% | -$231K |
|
|
ISEE
3008
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $544K | ﹤0.01% |
86,393
+18,506
| +27% | +$119K |
|
|
TPTX
3009
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $544K | ﹤0.01% |
6,963
-35,925
| -84% | -$2.65M |
|
3010
CALL
Dillards
DDS
$9.76B
| $543K | ﹤0.01% |
3,000
| – | – |
|
3011
CALL
iShares MSCI Mexico ETF
EWW
$1.98B
| $542K | ﹤0.01% |
+11,300
| New | +$533K |
|
3012
Energy Recovery
ERII
$470M
| $540K | ﹤0.01% |
23,683
-32,432
| -58% | -$639K |
|
3013
Koppers
KOP
$996M
| $539K | ﹤0.01% |
16,675
-13,884
| -45% | -$468K |
|
|
PRSU
3014
Pursuit Attractions and Hospitality Inc
PRSU
$1.42B
| $538K | ﹤0.01% |
10,804
-14,490
| -57% | -$641K |
|
3015
CRH
CRH
$66B
| $537K | ﹤0.01% |
10,569
+7,151
| +209% | +$358K |
|
3016
iShares Global Consumer Staples ETF
KXI
$1.07B
| $537K | ﹤0.01% |
8,780
+3,580
| +69% | +$218K |
|
|
MFNC
3017
DELISTED
Mackinac Financial Corporation
MFNC
| $536K | ﹤0.01% |
27,135
+6,633
| +32% | +$135K |
|
3018
Interface
TILE
$2.01B
| $534K | ﹤0.01% |
34,871
-50,444
| -59% | -$726K |
|
3019
Fossil Group
FOSL
$357M
| $533K | ﹤0.01% |
37,386
-27,350
| -42% | -$360K |
|
|
HTB
3020
HomeTrust Bancshares
HTB
$876M
| $529K | ﹤0.01% |
18,924
+6,007
| +47% | +$165K |
|
3021
Amplify Junior Silver Miners ETF
SILJ
$3.61B
| $528K | ﹤0.01% |
34,732
+27,019
| +350% | +$439K |
|
3022
Evolent Health
EVH
$349M
| $527K | ﹤0.01% |
24,954
-53,860
| -68% | -$1.08M |
|
3023
Invesco NASDAQ Internet ETF
PNQI
$549M
| $525K | ﹤0.01% |
10,225
+7,580
| +287% | +$365K |
|
3024
iShares Micro-Cap ETF
IWC
$1.52B
| $524K | ﹤0.01% |
3,437
+3,378
| +5,725% | +$501K |
|
3025
Artisan Partners
APAM
$3.06B
| $522K | ﹤0.01% |
10,283
-44,345
| -81% | -$2.33M |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.